Sarah Cannon Leadership and Physician Experts

Prior to his new role, Rob was the Co-Founder, Chief Business Development & Analytics Officer for Vidence, a healthcare data aggregation and analytics company. In addition, Rob has a 20+ year track record of success in oncology business development, strategy, health information technology, and quality in varied senior leadership roles with International Oncology Network, Cancer Treatment Centers of America, and the Geriatric Oncology Consortium.

Rob has also distinguished himself through service with nationally recognized organizations. Most notably, Rob was responsible for building CancerLinQ, one of the most innovative platforms in oncology at American Society for Clinical Oncology (ASCO). He currently serves on the Board of Directors for The University of Texas Pharmacy School Dean’s Advisory Board and has served in the past on several Advisory Boards including Doctor Helping Doctors Transform Healthcare.

Rob is excited to be part of the leading cancer network in the United States. He is looking forward to collaborating with the cancer teams, providers and hospital leaders throughout the network and especially across the North Texas Division.

In his free time, you can find Rob watching AAA baseball for his son, in the theater enjoying a dance recital for his daughter, struggling on the golf course, preparing a gourmet meal for his family, snowboarding, or out on the water relaxing. Please join Sarah Cannon and the North Texas Division in welcoming Rob to the team.